← Open Payments lookup

JOHN RAMSEY: Open Payments

NPI 1013558287 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,863 in 55 payments from 14 companies in 2025. Trend: 2023 $2,760 · 2024 $2,606 · 2025 $1,863

Food & beverage: $1,863
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$330
Gilead Sciences, Inc.3$323
ABBVIE INC.6$251
Axsome Therapeutics, Inc.7$218
ViiV Healthcare Company4$187
Otsuka America Pharmaceutical, Inc.6$186
Noven Therapeutics, LLC2$138
Vanda Pharmaceuticals Inc.3$72
Lundbeck LLC3$53
E.R. Squibb & Sons, L.L.C.2$41

Products named: CAPLYTA, VRAYLAR, Auvelity, APRETUDE, Biktarvy, Xelstrym, ABILIFY MAINTENA, Yeztugo.

Industry payments across NE — which companies pay providers there.